Literature DB >> 12776992

Regulation of dendritic cell function through Toll-like receptors.

Tsuneyasu Kaisho1, Shizuo Akira.   

Abstract

Higher animals establish host defense by orchestrating innate and adaptive immunity. This is mediated by professional antigen presenting cells, i.e. dendritic cells (DCs). DCs can incorporate pathogens, produce a variety of cytokines, maturate, and present pathogen-derived peptides to T cells, thereby inducing T cell activation and differentiation. These responses are triggered by microbial recognition through type I transmembrane proteins, Toll-like receptors (TLRs) on DCs. TLRs consist of ten members and each TLR is involved in recognizing a variety of microorganism-derived molecular structures. TLR ligands include cell wall components, proteins, nucleic acids, and synthetic chemical compounds, all of which can activate DCs as immune adjuvants. Each TLR can activate DCs in a similar, but distinct manner. For example, TLRs can be divided into subgroups according to their type I interferon (IFN) inducing ability. TLR2 cannot induce IFN-alpha or IFN-beta, but TLR4 can lead to IFN-beta production. Meanwhile, TLR3, TLR7, and TLR9 can induce both IFN-alpha and IFN-beta. Recent evidences suggest that cytoplamic adapters for TLRs are especially crucial for this functional heterogeneity. Clarifying how DC function is regulated by TLRs should provide us with critical information for manipulating the host defense against a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776992     DOI: 10.2174/1566524033479726

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  56 in total

1.  Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.

Authors:  Ofer Levy; Eugénie E Suter; Richard L Miller; Michael R Wessels
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  TLR9 is localized in the endoplasmic reticulum prior to stimulation.

Authors:  Cynthia A Leifer; Margaret N Kennedy; Alessandra Mazzoni; ChangWoo Lee; Michael J Kruhlak; David M Segal
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

3.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

4.  Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner.

Authors:  Hui Li; Lin Chen; Ying Zhang; Gene Lesage; Yi Zhang; Yan Wu; Gregory Hanley; Shenggang Sun; Deling Yin
Journal:  J Neuroimmunol       Date:  2010-12-22       Impact factor: 3.478

Review 5.  Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.

Authors:  T R D J Radstake; A W T van Lieshout; P L C M van Riel; W B van den Berg; G J Adema
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

6.  Invariant NKT cells sustain specific B cell responses and memory.

Authors:  Grazia Galli; Paola Pittoni; Elena Tonti; Carmine Malzone; Yasushi Uematsu; Marco Tortoli; Domenico Maione; Gianfranco Volpini; Oretta Finco; Sandra Nuti; Simona Tavarini; Paolo Dellabona; Rino Rappuoli; Giulia Casorati; Sergio Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

7.  MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

Authors:  Barbara C Baudner; Vanessa Ronconi; Daniele Casini; Marco Tortoli; Jina Kazzaz; Manmohan Singh; Lynn D Hawkins; Andreas Wack; Derek T O'Hagan
Journal:  Pharm Res       Date:  2009-03-03       Impact factor: 4.200

8.  Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.

Authors:  Garry L Morefield; Lynn D Hawkins; Sally T Ishizaka; Teri L Kissner; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

9.  Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling.

Authors:  Yi Zhang; Ying Zhang; Junying Miao; Gregory Hanley; Charles Stuart; Xiuli Sun; Tingting Chen; Deling Yin
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

Review 10.  A recent perspective on alcohol, immunity, and host defense.

Authors:  Gyongyi Szabo; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2008-12-02       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.